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The development of the anterior segment of the mammalian eye is
critical for normal ocular function, whereas abnormal development
can cause glaucoma, a leading cause of blindness in the world. We
report that orphan G protein-coupled receptor 48 (Gpr48/LGR4) plays
an important role in the development of the anterior segment
structure. Disruption of Gpr48 causes a wide spectrum of anterior
segment dysgenesis (ASD), includingmicrophthalmia, iris hypoplasia,
irdiocorneal angle malformation, cornea dysgenesis, and cataract.
Detailed analyses reveal that defective iris myogenesis and ocular
extracellular matrix homeostasis are detected at early postnatal
stages of eye development, whereas ganglion cell loss, inner nuclear
layer thinness, and early onset of glaucoma were detected in
6-month-old Gpr48/mice. To determine the molecular mechanism
of ASD caused by the deletion of Gpr48, we performed gene expres-
sion analyses and revealed dramatic down-regulation of Pitx2 in
homozygous knockout mice. In vitro studies with the constitutively
activeGpr48mutant receptor demonstrate that Pitx2 is a direct target
of the Gpr48-mediated cAMP-CREB signaling pathway in regulating
anterior segment development, suggesting a role of Gpr48 as a
potential therapeutic target of ASD.
eye development  glaucoma  cataract  Lgr4
The function of the vertebrate retina, which transduces light intoelectrical signals to the brain, depends on a considerable
number of highly differentiated tissues in the anterior eye segment.
Cornea and lens provide transparency and refraction, the iris
protects the retina from excess exposure of light, and the ciliary
body (CB) secretes aqueous humor that flows between the lens and
the anterior chamber to provide nutritional needs for the lens and
cornea. Malformation of the anterior structures in the eye can
dramatically affect vision function and blockage of aqueous humor
outflow, leading to the increase of intraocular pressure (IOP) (1, 2).
Chronic IOP is an important risk factor for glaucoma, a leading
blindness disease in the world, affecting70million individuals (3).
G protein-coupled receptors (GPCRs) play key roles in a variety
of physiological functions. Gpr48, also called LGR4, belongs to the
leucine-rich GPCR (LGR) family (4–6). Members of this family
have multiple leucine-rich repeats at the N terminus and a seven-
transmembrane domain (7). Many studies suggest that the expand-
ing family of LGRs, including three known glycoprotein hormone
receptors (LH, FSH, and TSH), the orphan receptor LGR4
(Gpr48)-LGR6, and LGR7–8, are homologous and conservative
(4–7). The mammalian glycoprotein hormone receptors have di-
verse structural features and mainly couple through the cAMP-
dependent pathway for signal transduction (4–6). Gpr48 is widely
expressed inmultiple organs at both the embryonic and adult stages
(8, 9), suggesting a vital role in development and adult physiological
functions. Recent studies demonstrate that Gpr48/LGR4 plays
important roles in growth retardation and renal and reproductive
system development (9–11). Furthermore, up-regulation of Gpr48
promotes carcinoma cell invasion and metastasis (12). However, so
far little is known about the function and molecular mechanism of
Gpr48 in eye development and dysgenesis.
To understand the biological function of Gpr48, we have gen-
erated Gpr48-null mice by using the gene-trap technique and
examined the expression of Gpr48 in eye [see supporting informa-
tion (SI) Figs. S1 and S2 and SI Text). We demonstrate that
Gpr48-null mice have a spectrum of anomalies in the anterior
segment of the eye, including microphthalmia, iris hypoplasia,
irdiocorneal angle malformation, cornea dysgenesis, and cataract.
At early stages of eye development, we found that Gpr48/
homozygous mutant mice have decreased iris myogenesis and
defective extracellular matrix homeostasis. Detailed study of the
expression levels of different transcription factors demonstrates
that Pitx2 is dramatically down-regulated in Gpr48-null mutant
mice. We further demonstrate that Gpr48 can increase the intra-
cellular cAMP level, which activates cAMP-dependent PKA and
directly regulates Pitx2 expression through CREB transcription
factor binding to the Pitx2 promoter. Together, our studies dem-
onstrate that Gpr48 regulates ocular anterior segment develop-
ment. Disruption of Gpr48 function can lead to anterior segment
dysgenesis (ASD) through down-regulation of Pitx2, a key tran-
scription factor in anterior segment development (13–15), suggest-
ing Gpr48 as a potential therapeutic target of ASD.
Results
Gpr48 Disruption Induces Microphthalmia, Iris Hypoplasia, and Iridio-
corneal Abnormality. To explore the biological function of Gpr48 in
vivo, we generated Gpr48 homozygous mutant mice (Gpr48/
mice) by microinjecting gene trap-mutated Gpr48 ES cells into
blastocysts of C57BL/6 mice. The Gpr48/ mice demonstrated
growth retardation in the embryo and postnatal day 0 (P0) mice,
and their weight was 60–70% of their wild-type littermates.
Gpr48/ mice show a perinatal death phenotype, and 60% of
newborn homozygous mice die around P0 and day 1, which is
consistent with previous reports (9). Although the mortality of
Gpr48/mice is high at P0 and day 1, themortality of mutant mice
is decreased significantly after day 1.Of 47 adultGpr48/mice that
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survived, there are 20Gpr48/male and 27Gpr48/ femalemice.
Initial examination shows that 15 of 20Gpr48/male mice (75%)
showed a small eye phenotype (microphthalmia), and 10 of 27
female mice have a small eye phenotype (37%) (Fig. 1a).
Because the small eye phenotype is frequently associatedwith iris
hypoplasia and the expression ofGpr48 in the iris stroma,we further
examined whether Gpr48/ mice have iris hypoplasia using Slit
Lamp assays.When exposed to strong light, the iris of the wild-type
mice expanded and formed a dark-brown layer in front of the lens
to prevent too much light from entering the eyes. However, in
Gpr48/mice, a dark-brown layerwas not formed, and only a small
layer of brown tissue can be detected at the rim of the cornea,
indicating that Gpr48/ mice have iris hypoplasia (Fig. 1b). Upon
close histological examination, we found that the iris in Gpr48/
mice wasmuch shorter and thinner than in wild-typemice (Fig. 1c).
The pupil diameter is significantly increased inGpr48/mice (Fig.
1c). Histology analysis also revealed that the stroma portion of the
iris is dramatically reduced in the Gpr48/ mice (Fig. 1d, H&E
staining). In the pupil portion of the wild-type iris, the stroma part
is large, with a large number of stroma cells (25–35 cells per pupil
iris, DAPI staining). InGpr48/mice, however, the size of the iris
stroma is small, with decreased stroma cells (12–18 cells per pupil
iris, Fig. S3d, DAPI staining). The total thickness in themiddle part
of the iris stroma is also dramatically reduced in Gpr48/ mice
(Fig. 1d Right). Because the iris stroma contains smooth muscle
cells, we further examined whether iris smooth muscle was hyp-
oplasic in Gpr48/ mice using smooth-muscle actin (SMA) im-
munofluorescence staining.We found that the staining of SMAwas
dramatically weaker in Gpr48/ compared with wild-type mice
(Fig. 1d, SMA staining), suggesting that deletion of Gpr48 in mice
induces iris smoothmuscle hypoplasia. In P4mice, we found similar
reduced SMA immunofluorescence staining inGpr48/mice (Fig.
1e), indicating that early iris muscle development was defective in
Gpr48/ mice. These data are further confirmed by the down-
regulated expression of MyoD1, Mf5, Msc, and Smy1D in P0
Gpr48/ mice (Fig. 1f). Although the degree of iris hypoplasia
varies from mouse to mouse, all Gpr48/ mice we examined have
iris hypoplasia.
Iridocorneal structure malformation was found in all Gpr48/
mice with different degrees of defects (Fig. 1g, Fig. S4, and Table
S1). The iridocorneal angle is smaller inGpr48/mice. In extreme
cases (3 of 24 Gpr48/ mice), the corneal angle was totally closed
because of the adhesion of the iris with the cornea (Fig. 1g). TheCB
is much smaller in allGpr48/mice compared with wild type (Fig.
1h), containing less folding and fewer cells in the folding (Fig. 1h,
middle arrow). The trabecular meshworks (TM) in Gpr48/ mice
are also compressed and containmany fewer trabecular beams with
Fig. 1. Microphthalmia, iris hypoplasia, and iridiocorneal abnormality inGpr48/mice. (a) Microphthalmia inGpr48/mice. (b) Iris hypoplasia demonstrated
by Slit lamp examination of adult mice. Gpr48/ mice have hypoplasia of the iris with a larger pupil (arrows) relative to wild-type mice under strong light
exposure. (c) Midsagittal sections of the entire eye showing short iris and bigger pupil in Gpr48/ (/) compared with wild-type mice (/). Detailed analysis
of 24 Gpr48/ and wild-type mice indicates the iris length is significantly shorter, whereas the pupil size is much bigger in Gpr48/ compared with wild-type
mice. (d) Smooth muscle hypoplasia and reduction in cell numbers in the iris ofGpr48/mice. The pupil part of iris inGpr48/mice is much smaller than in wild
type. The middle part of the iris inGpr48/mice is much thinner than in wild type (H&E staining). The stroma portion in theGpr48/ iris can hardly be detected.
SMA staining of the iris smooth muscle cell in adult mice demonstrates a decrease of SMA in both the pupil and the middle portions of iris muscle cells inGpr48/
mice (SMA staining). DAPI staining indicates that the number of cells was significantly reduced in both the stroma and the middle portion of the iris in Gpr48/
mice (DAPI). (e) Iris myogenesis in postnatal day 4 Gpr48/ mice. H&E staining shows that the iris is short and small in postnatal day 4 Gpr48/ compared with
wild-type mice. SMA immunofluorescence staining is weak in Gpr48/ compared with wild-type mice. ( f) The expression levels of key genes in myogenesis,
includingMf5, Smy1D1,MyoD1, andMsc, were significantly decreased in P0Gpr48/mice. (g) Iris–cornea adhesion and close of iridocorneal angle were detected
in Gpr48/ mice. (h) Iridocorneal structure anomalies in Gpr48/ mice. The CB of Gpr48/ mice contains less folding and fewer cells in the outer layer of the
CB. The TM is compressed in Gpr48/ compared with wild-type mice. C, cornea; I, iris; L, lens; P, pupil; R, retina. [Scale bars: 170 m (c), 43 m (d), and 85 m
(e–h).]
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smaller beam size than those in wild-type mice. Schlemm’s canal
(SC) was much smaller in both length and width (Fig. 1h Bottom).
Keratopathy and Cornea Dysgenesis in Gpr48/ Mice. Careful ex-
amination ofGpr48/mouse eyes reveals that40% (18 of 47) of
the mutant mice also have cornea opacity. A cloudy white non-
transparent structure formed in the center or around the rim of the
cornea (Fig. S3a). Most of these mice (15 of 18) also have cornea
neovascularization (Fig. S3a). Histological analyses reveal that
other keratopathies also exist, including cornea inflammation and
neovasculization (Fig. 3b IF, 10%, 5 of 47); cornea epithelial plug
(Fig. S3b, 16%, 8 of 47); cornea vascular pannus (Fig. S3b, 8%,
4 of 47); cornea cystic-like lesion (Fig. S3b, 10%, 5 of 47), and loss
of surface smoothness (Fig. S3b, 8%, 4 of 47). The appearance of
keratopathy was more frequently found in male and old Gpr48/
mice than in female and young mice, indicating that the protective
function of the cornea epithelium is compromised inGpr48mutant
mice.
To evaluate whether the cornea epithelium has a developmental
defect, we examined cornea epithelium morphology at both the
early postnatal periods and in adult mice (Fig. S3c). At day 0, both
mutant and wild-type mice have one to two layers of cornea
epithelial cells, and the cornea stroma is not different from that in
wild-type mice. Beginning at P10, however, the cornea epithelium
layers ofmutantmice become significantly thinner than in wild type
(Fig. S3c, P10 andP14).H&E staining demonstrates that cells in the
mutant cornea appear shrunken and more compact compared in
wild-typemice (Fig. S3c, P10 and P14). These changes in the cornea
epithelium continue in adult mice (Fig. 3c, 2M). Further studies of
the cornea epithelium demonstrate that both cell proliferation [Fig.
S3d, proliferating cell nuclear antigen (PCNA)] and cell differen-
tiation (Fig. 3d, K12) are decreased in Gpr48-null mutant mice, as
demonstrated by marker staining. Besides cornea epithelium thin-
ness, the cornea stroma of adultGpr48/mice is also significantly
thinner than in wild type (Fig. S3e).
To see whether the structure of the collagen fibers was normal
in mutant mice, we performed electronic microscopic analysis of
Gpr48-null mutant mice. We found that the lamellar arrange-
ment of collagen in the mutant cornea was seriously disturbed in
Gpr48-null mutant mice (Fig. S3f ). The cornea fibrils cross each
other randomly and leave significant portions of electron lucent
space in the cornea stroma of Gpr48/ mice (Fig. S3f ). In wild
type, however, collagen fibrils are arranged in a regular lamellar
structure, crossing each other at right angles and forming a highly
ordered 3D structure in the cornea (Fig. S3f Left).
The expression levels of key extracellular matrix proteins, includ-
ing collagen I, collagen V, biglycan (BGN), osteoglycan (OGN),
keraton, decorin (Den), and lumican were decreased in newborn
Gpr48/ mouse eyes (Fig. S3g). PLOD1 and PLOD2, two key
enzymes that regulate collagen homeostasis (16), are also de-
creased in Gpr48/ mice, as measured by real-time PCR analysis
in newborn mouse eyes (Fig. S3h), suggesting the disruption of the
extracellular matrix protein homeostasis in the cornea ofGpr48/
mice.
Cataract and Early Onset of Glaucoma in Gpr48/ Mice. We found
that 26% (13 of 47) of Gpr48/ mutant mice have cataracts by
using the Slit Lamp test (Fig. 2a). The white nontransparent
structure located in the lens of Gpr48/ mice was detected (Fig.
2a). Lens opacity ranged from total (Fig. 2a, TL) to partial lens
opacity (Fig. 2a, PL). Some mutant mice have both opaque lenses
associated with iris-corneal adhesion (Fig. 2a, arrow). Upon histo-
logical analysis, we found that mutant lens fibers are disorganized
and abnormally larger in the cortical zone of lens inGpr48/mice
with cataract (Fig. 2b). Abnormal protein deposits are detected in
some lens cells (Fig. 2b, arrow). In those mutant mice that do not
have apparent lens fiber anomalies, the lens diameter was signifi-
cantly reduced (Fig. 2c) (P  0.02). Because A-crystallin is the
major protein in the lens, we examined the expression level of
A-crystallin byWestern blot analysis with equal weight of lens.We
found that the ratio of soluble and insoluble A-crystallin was
significantly different between wild-type and mutant Gpr48/
mice (Fig. 2d). A large amount of insoluble protein can be detected
inmutant but not in wild-typemice (Fig. 2d, insoluble), which could
explain the abnormal protein deposits in the mutant mouse lens.
Further analysis reveals that the promoter of A-crystallin can be
directly activated by cotransfection of Gpr48 constitutively active
mutant receptor in the cells (Fig. 2e), suggesting that A-crystallin
is a direct downstream target regulated by Gpr48 activation.
To determine whether deletion of Gpr48 induces early onset of
glaucoma, we examined the morphology changes of the retinas of
Gpr48/ and wild-type mice. The retinas from Gpr48/ mice
younger than 6 months seem normal. However, in 10 of 24
Gpr48 /mice older than 6 months, we detected significant loss of
ganglion cells and thinness and disarrangement of inner and outer
nuclear cell layers, respectively (Fig. 2f), suggesting that Gpr48
could play an important role in the early onset of glaucoma.
Down-Regulation of the Key Transcription Factor, Pitx2, in Gpr48/
Mice. To determine how Gpr48 deficiency causes anterior segment
structure changes, we analyzed the expression levels of transcription
factors important for eye development with P0 mouse eyes. As
shown in Fig. 3a, the expression levels of Foxc1, Foxc2, Foxe3,
Lmx1b1, and Pax6 are not changed (Fig. 3a), nor are Pitx3, Bmp4,
Atf4, Mitf, C-myb, Prox-1, Eya-1, and Sox2 in the eyes of Gpr48/
Fig. 2. Cataract and ganglion cell loss in Gpr48/ mice. (a) Lens opacity in
Gpr48/ mice. Total and partial lens opacity and iris cornea adhesion are
detected inGpr48/mice. (b) Histological analysis shows abnormal lens fibers
in the lens cortical zone of Gpr48/ mice. Abnormal protein deposit is also
detected (arrow) (32). (c) Statistical analysis shows Gpr48/ have smaller lens
compared with wild-type mice. (d) The ratio of soluble and insoluble A-
crystallin has been changed in Gpr48/ mice with significant increase of
insoluble A-crystallin in Gpr48/ mice. (e) Activation of A-crystallin pro-
moter reporter by Gpr48 active mutant T755I. ( f) Ganglion cells loss and
thinning of inner and outer nuclear layers inGpr48/mice at 6 months. [Scale
bars: 340 m (b) and 100 m ( f).]














mice (data not shown). However, the expression level of Pitx2 is
significantly down-regulated in Gpr48/ mice (Fig. 3a). The sig-
nificant down-regulation of the Pitx2 gene and Pitx2 protein was
further confirmed by RT-PCR (Fig. 3b), in situ hybridization assays
with Pitx2 probes (Fig. 3d), and Western blot analysis, with the
specific anti-Pitx2 antibody (Fig. 3c), suggesting that Pitx2 is a
potential downstream target gene regulated by Gpr48. As controls,
the expression levels of Foxc1 and Pax6 are not changed in
Gpr48/ mice in our in situ hybridization assays and immuno-
fluorescence staining (Fig. 3d). Together, our data demonstrate
that deletion ofGpr48 significantly decreases the expression level of
Pitx2, a key transcription factor in anterior segment development of
the eyes.
Gpr48 Mediates the cAMP-PKA and CREB Signaling Pathway. To
examine the downstream signaling pathways mediated by Gpr48,
we generated six mutant receptors, four in the transmembrane
domain V and VI regions (D736G, T755I, T755L, and I758G) and
two mutants in the third intracellular loop (H748V and A750V) of
the wild-type Gpr48 receptor (data not shown). After transfecting
thesemutant receptors into 293T cells, wemeasured the production
of intracellular cAMP and found that one of the mutants, T755I,
could significantly increase the intracellular cAMP level compared
with cells transfected with the wild-type Gpr48 receptor and the
control vector (Fig. 4a), consistent with the data published previ-
ously (17). The activation of the cAMPpathway was also confirmed
by the activation of the CREB luciferase reporter assay in cells
cotransfected with the T755I mutant receptor (Fig. 4b), suggesting
that Gpr48 activates Gs and adenylate cyclase to produce intra-
cellular cAMP, which activates the CREB transcription factor
(Fig. 4b).
Gpr48 Regulates Pitx2 Expression Through the CREB Transcription
Factor and the CRE-Binding Site of the Pitx2 Promoter.Tounderstand
themolecular mechanisms of reduced Pitx2 expression inGpr48/
mice, we examined 2 kb of the Pitx2 promoter region from both
human and mouse Pitx2 genes using online computer software
TESS (www.cbil.upenn.edu/cgi-bin/tess/tess). A consensusCRE site
TGACGTCA for potential binding by the CREB transcription
factor was identified at position 79 relative to the transcription
start site ofPitx2 in both species (Fig. 4c). Todeterminewhether this
sitewas important for the activation of thePitx2promoter byGpr48,
we constructed different Pitx2-luciferase reporter genes with or
without the CRE-binding site (Fig. 4c). We measured luciferase
activity in cells transfected with the reporter genes and the Gpr48
wild-type or active mutant (T755I) receptor, respectively. As shown
in Fig. 4d, the active mutant of Gpr48 can activate the Pitx2-108-luc
reporter that contains the CRE site but not the Pitx2-67-luc
reporter in which the CRE-binding site was deleted (Fig. 4d). This
activation is also diminished by point mutation of the CRE-binding
site (fromTGACGTCA to TGAAATCA) (Fig. 4e), indicating that
theCRE-binding site is essential for activation of thePitx2 promoter
by Gpr48 activation (Fig. 4e). Furthermore, we demonstrated that
activation of the Pitx2 promoter by Gpr48 is through a cAMP-
dependent protein kinase (PKA) signaling pathway, because both
competitive PKA inhibitors, PKI and H-89, can successfully inhibit
the activation of the Pitx2-luciferase promoter mediated by the
Gpr48 active mutant receptor (Fig. 4 f and g).
To further confirm thatGpr48 activate thePitx2 promoter via the
cAMP-CREB signaling pathway, we examined the interaction of
CREB with the Pitx2 promoter using EMSA and ChIP assays. As
shown in Fig. 4h, nuclear extracts from mouse pituitary cell T3–1
form a binding complex with the [32-P]-labeled Pitx2-CRE probe
(spanning sequence from99 to69 in the promoter region of the
mousePitx2) (Fig. 4h, lane 2, arrow). This bandwas not supershifted
by nonspecific IgG and mutant probes (Fig. 4h, lanes 4 and 5) but
was supershifted by the specific anti-CREB1 antibody (Fig. 4h, lane
6) and blocked by the 200-fold cold competitor probe (Fig. 4h, lane
3), suggesting specific binding of the CREB transcription factor to
the Pitx2 promoter. In the ChIP assay, we further found that the
specific CREB antibody was capable of immunoprecipitating the
Pitx2 promoter fragment containing the CRE sites (Fig. 4i, lane 3)
but not by the anti-IgG antibody (Fig. 4i, lane 2). Together, our data
demonstrate that Gpr48 can regulate Pitx2 gene expression through
the cAMP-PKA-CREB signaling pathway, and that the CRE-
binding site (9) in the promoter region of Pitx2 is essential for the
regulation of Gpr48 activation (Fig. 4j).
Discussion
The findings presented here demonstrate that Gpr48 regulates the
development of the anterior chamber of the mouse eye. Deficiency
of Gpr48 resulted in a spectrum of ASD, including iris hypoplasia,
iridocorneal angel malformation, corneal dysgenesis, and cataract.
Detail analysis of the anterior segment of the eyes at early stages of
development reveals significant defects in irismyogenesis, in cornea
epithelial cell proliferation and differentiation, and in the synthesis
of extracellular matrix molecules in Gpr48/ mice. All of these
defects have led toASD in adultmice. To understand themolecular
mechanisms of Gpr48-mediated ASD, we found that Pitx2 was
significantly down-regulated in Gpr48-null mutant mice, and Pitx2
is a direct target of Gpr48 through cAMP-PKA and CREB
signaling pathways. Therefore, deletion of Gpr48 results in ASD
through decreased Pitx2 expression, a key transcription factor in
anterior segment development (18).
Gpr48-null mutant mice have iris hypoplasia, as demonstrated
by the Slit Lamp assay. Histological analysis demonstrated that
the early stage of iris muscle development in theGpr48/mouse
was significantly affected with diminished expression of SMA
and the down-regulation of myogenesis biomarkers and tran-
scription factors. The iris smooth muscle in the iris stroma
Fig. 3. Expression changes of key transcription factors in Gpr48/ mouse
eyes. (a) Real-time PCR analysis of transcription factors involved in ocular
anterior development shows that Pitx2 is down-regulated in P0 Gpr48/
mice. The expression levels of Foxc1, Foxc2, Foxe3, Lmx1b1, and Pax6 are not
changed. (b) The expression levels of transcription factors, including Pitx2,
Foxc1, Foxc2, Foxe3, Lmx1b1, and Pax6, were confirmed by RT-PCR, showing
decreased expression of Pitx2 in the E12.5 Gpr48/ embryo. (c) Decreased
expression of Pitx2 protein using Western blot analysis with the E12.5-day
embryo in Gpr48/ mice. (d) Whole-mount in situ hybridization (Pitx2 and
Foxc1) and immunofluorescence staining (Pax6) in the E12.5 embryo demon-
strates that Pitx2, but not Foxc1 and Pax6, was significantly decreased in the
Gpr48/ embryo. [Scale bars: 85 m (b).]
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controls the expansion and constriction of iris pigment epithelial
cells, so the proper amount of light can enter the eyes. Again,
Pitx2 was identified as one of the key genes regulating iris
development (19). Down-regulation of Pitx2 leads to defects in
iris development (20). In Pitx2 heterozygous mice, the iris was
hypoplastic, and the periocular muscle was diminished (13, 20).
In Gpr48/ mice, keratopathy was frequently detected, indicat-
ing the protective function of the cornea epithelium, and the
integrity of the cornea may be compromised. At early stages of eye
development, we found that cornea epithelial cell proliferation and
differentiation are dramatically decreased in Gpr48/ mice, re-
sulting in a thin and poorly developed cornea epithelium. The
cornea contains a large number of extracellular matrix proteins
important for cornea homeostasis. In Gpr48/ mice, the expres-
sion levels of corneal extracellular matrix molecules, including
collagen I, collagen V, BGN, OGN, keraton, Den, and lumican
(21), are all decreased in Gpr48-null mutant mice. Collagen I and
V provide the structural support for the cornea, whereas proteo-
glycans, including lumican, keratocan, OGN, Den, and BGN,
function to coordinate the collagen fibril diameter and collagen
fibril interspacing (22). Down-regulation of these molecules has
been demonstrated to affect collagen structure, cornea clarity, and
the homeostasis of corneal cells (23). Furthermore, we found that
deletion of Gpr48 significantly decreased the expression levels of
two key enzymes, Plod1 and Plod2, that are responsible for hy-
droxylizing lysines in collagens through the down-regulation of
Pitx2. It has been shown that both PLOD1 and PLOD2 promoters
contain multiple PITX2-binding elements and are regulated by
PITX2 in the pathology of Rieger syndrome (16), suggesting that
PLOD1 and PLOD2 are indirect targets ofGPR48 through PITX2.
In 26% (13/47) of Gpr48-null mutant mice, we detected lens
opacity with abnormal large lens fiber cells and insoluble lens
protein in the cells, indicating the occurrence of cataract. This
phenotype is similar to A-crystallin knockout mice, in which
mutant mice develop lens cataract (24). In fact, the decreased
soluble A-crystallin protein level and increased insoluble A-
crystallin protein in Gpr48/ mouse eyes indicate that Gpr48 is
important for A-crystallin stability in the lens. In Gpr48/ mice
6 months of age, we did not detect any significant difference of
themutant retina fromwild type. However, ganglion cell loss, inner
nuclear layer thinness, and outer nuclear layer disorganization are
frequently observed in Gpr48-null mice older than 6 months.
Because ganglion cell loss and thinness of the inner nuclear cell
layer are early indicators of glaucoma (19), our data suggest that
Gpr48 could play an important role in the early onset of glaucoma
and its development.
To understand the molecular mechanisms that mediate ASD in
Gpr48/ mice, we analyzed the expression levels of 20 different
transcription factors and found that Pitx2 was significantly down-
regulated in the Gpr48/ mouse. PITX2 is a homeodomain tran-
scription factor implicated as the gene responsible for Atenfield–
Rieger Syndrome (ARS) in humans (25). ARS is an autosomal
dominant genetic disorder characterized by malformation of mul-
tiple tissues, including iris hypoplasia and iridogoniodysgenesis
syndrome (15). Forty percent of patients diagnosed with classical
ARS have PITX2 mutations (26). Pitx2 is a key gene for mesen-
chymal epithelial transmission, regulating both craniofacial myo-
genesis and extracellular matrix synthesis in heart and cornea (20,
27). We identified and characterized the binding of the CREB
transcription factor to a consensusCREsite at position79 relative
to the transcription start site of the Pitx2 promoter using promoter
Fig. 4. Regulation of Pitx2 expres-
sion by Gpr48 through cAMP-PKA-
CREB signaling pathway. (a) Activa-
tion of cAMP production by
constitutively active Gpr48 mutant
(T755I). (b) Activation of CRE lucif-
erase reporter activity by Gpr48
T755I mutant receptor. (c) Diagram
of the CRE-binding site in the Pitx2
promoter and two Pitx2 luciferase
reporters: luc-108, which contains
the CRE site, and luc-67, which does
not. (d) Activation of Pitx2 108-luc
reporter by Gpr48 active mutant
(T755I). Pitx2 67-luc reporter (no
CRE-binding site) was not activated
by the active mutant receptor. (e)
Point mutation of the CRE site
(from TGACGTCA to TGAAATCA) of
thePitx2promoter dramatically de-
creased the activation by Gpr48 ac-
tive receptor (T755I). ( f and g) PKI
and H-89 inhibit the activation of
the Pitx2 108-luc reporter mediated
by the Gpr48 active receptor, re-
spectively. (h) Binding of CREB tran-
scription factor to the CRE-binding
site of the Pitx2promoter region by
EMSA assays. Lane 1, free probe;
lane 2, nuclear extract from T3–1
cells showing strong binding with
Pitx2 CRE probe; lane 3, 200-fold
cold Pitx2 CRE probe successfully
shifted the binding; lane 4, 200-fold
mutantPitx2CRE probe failed to shift the band; lane 5, anti-IgG antibody did not shift the binding of the CRE probe; lane 6, anti-CREB antibody successfully shifted
the binding complex of the Pitx2 CRE probe. (i) ChIP assays of the CRE site in the Pitx2 promoter demonstrate that anti-CREB antibody can successfully precipitate
the DNA fragment in the promoter region of Pitx2. (j) Diagram of Gpr48 signaling pathways and regulation of ASD by Gpr48 through down-regulation of Pitx2
expression. Activation of Gpr48 leads to the production of intracellular cAMP and the activation of PKA. PKA can phosphorylate and regulate the activity of CREB,
a key transcription factor that regulates the expression levels of many key genes, such asPitx2andA-crystallin, in anterior segment development and dysgenesis.














luciferase, EMSA, and ChIP assays. Therefore, our studies dem-
onstrate that Gpr48 can regulate the expression level of Pitx2
through the cAMP-PKA-CREB pathway, and that the CRE-
binding site at 79 in the promoter of Pitx2 specifically mediates
this activation. Although there is evidence that Pitx2 is partially
controlled by the nodal signaling pathway (28), our studies provide
strong evidence that GPCR and the G protein-mediated cAMP-
PKA-CREB pathway can directly regulate the expression level of
a key transcription factor Pitx2 during development, suggesting that
Gpr48 may regulate eye and other organ development through the
regulation of Pitx2.
To understand the signaling pathways mediated by Gpr48, we
generated the ligand-independent constitutively active mutant re-
ceptor of Gpr48 (T755I). We demonstrate that this agonist-
independent (constitutively) active mutant receptor can increase
intracellular cAMP concentration and activate the intracellular
cAMP-CREB signaling pathway. Receptors coupled to heterotri-
meric GTP-binding proteins (G proteins) are integral membrane
proteins and are targets for50% of the pharmaceutical products
sold in the world (29, 30). The study presented here suggests that
Gpr48 is very important for anterior segment development of the
eyes. Disruption ofGpr48 causes ASD through down-regulation of
the Pitx2 gene, suggesting that Gpr48 could be a potential thera-
peutic target in the treatment of ASD.
Materials and Methods
Generation of Gpr48 Gene Trap Mice. TheGpr48 gene trap ES cell clone (LST020)
was obtained from Williams Skarnes (Bay Genomics) (31, 32). The Gpr48-null ES
cell clones were injected into C57BL/6 blastocysts and transferred to ICR females.
MalechimeramicewerematedwithC57BL/6 females, resulting intransmissionof
the inserted allele to the germ line. Positive mice were interbred and maintained
on a mixed 129 C57BL/6 background.
Cell Proliferation and Apoptosis Assays. For PCNA staining, the Zymed PCNA
Staining Kit (Zymed Laboratories) was used. For apoptosis assays, the ApopTag
Plus Peroxidase In Situ Apoptosis Detection Kit from Chemicon was used. The
pictures were captured on a CCD camera mounted on an inverted research
microscope.
Mouse Pitx2 Reporter Constructs. The mouse Pitx2 proximal promoter region
was obtained by PCR using mouse genomic DNA, then subcloned to pGL3-Basic
Vector (Promega). For generation of the point mutation of CREB binding on
the promoter region, forward primer: F; 5-GTGGAAT CTCTGC TGAAATCACG
AC ACTCC-3 and reverse complement primer were used. All constructs en-
compassing the promoter region of mouse Pitx2 were cloned into the pro-
moterless pGL3 Basic Vector (Promega). The sequence of the constructs was
verified by sequencing.
ChIP Assays. ChIP assays were performed as described (33). Briefly, T3–1 cells
were grown in 100-mm tissue culture plates, fixed with 1% formaldehyde, and
lysed in SDS lysis buffer containing 1 mM phenylmethylsulfonyl fluoride, 1g/ml
aprotinin,and1g/mlpepstatinA.DNAwasshearedtofragmentsof200–500bp
by seven 10-s sonications. The chromatin was precleared with salmon sperm
DNA/protein A-agarose slurry (Upstate Biotechnology) for 1 h at 4°C with gentle
agitation. The agarose beads were pelleted, and the precleared supernatant was
incubated with antibodies to CREB overnight at 4°C. The region between161
and 1 of the Pitx2 promoter was amplified from the immunoprecipitated
chromatinbyusingthefollowingprimers: sense,5-TGATCGCCCAGCGTACAG-3,
and antisense, 5-CTCGGTCTCGCACTCTCTCT-3.
Data Analysis. All experimental data are presented as the mean 	 SEM.
Statistical significance was determined by the Mann–Whitney U test and
Student’s t test. Significance was accepted at P  0.05.
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